Advertisement

Topics

CMP Pharma Announces FDA Approval Of CaroSpir (Spironolactone Oral Suspension, 25 Mg/5 mL)

20:00 EDT 6 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: CMP Pharma Announces FDA Approval Of CaroSpir (Spironolactone Oral Suspension, 25 Mg/5 mL)

NEXT ARTICLE

More From BioPortfolio on "CMP Pharma Announces FDA Approval Of CaroSpir (Spironolactone Oral Suspension, 25 Mg/5 mL)"

Quick Search
Advertisement